EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Momenta Nabs $57.4M in Stock Offering

Cambridge, MA-based Momenta Pharmaceuticals (NASDAQ: MNTA) said today it has raised $57.4 million through a stock offering. The company sold 4 million new shares of common stock at $14.35 apiece, about a 5.5 percent discount to yesterday’s closing stock price of $15.18. UBS was the lead underwriter of the deal, while Cowen & Company and Canaccord Genuity served as co-managers.